中国科技核心期刊
中国科技论文统计源期刊
中文生物医学期刊文献数据库
中国科学引文数据库(CSCD收录)
中国学术期刊综合评价数据库统计源期刊
《中国学术期刊影响因子年报》统计源期刊
Chinese Journal of Blood Purification ›› 2022, Vol. 21 ›› Issue (03): 149-152.doi: 10.3969/j.issn.1671-4091.2022.03.002
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Contact:
Abstract: 【Abstract】Patients with end-stage renal disease (ESRD) on maintenance hemodialysis have a high incidence of hyperkalemia, and with the deterioration of renal function, the risk of recurrence of hyperkalemia gradually increases. Many factors, including inappropriate dialysis, concomitant use of drugs that raise serum potassium, and certain medical conditions, increase the risk of hyperkalemia in dialysis patients. Hyperkalemia in dialysis patients is closely related to its poor prognosis, not only increasing the risk of death, but also increasing the number of emergency department visits and hospitalizations, and medical costs. Therefore, for HD patients with recurrent hyperkalemia, attention should be paid to the comprehensive management of serum potassium levels, including restriction of high potassium diet, adequate dialysis treatment, avoidance of drugs that increase serum potassium, and rational use of potassium-lowering drugs.
Key words: Hemodialysis, End strage renal disease, Hyperkalemia, Clinical risks
CLC Number:
R459.5
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.cjbp.org.cn/EN/10.3969/j.issn.1671-4091.2022.03.002
https://www.cjbp.org.cn/EN/Y2022/V21/I03/149